Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-24 9:59 pm Purchase |
2025-02-14 | 13D | IntelGenx Technologies Corp. IGXT |
Apeiron Investment Group Ltd. | 44,908,967 22.700% |
44,908,967 (New Position) |
Filing History |
| 2025-01-28 4:30 pm Purchase |
2025-01-24 | 13D | Neuphoria Therapeutics Inc. NEUP |
Apeiron Investment Group Ltd. | 72,618 4.500% |
72,618 (New Position) |
Filing History |
| 2024-10-07 6:10 pm Purchase |
2024-10-03 | 13D | Bionomics Limited BNOX |
Apeiron Investment Group Ltd. | 23,040,875 8.900% |
23,040,875 (New Position) |
Filing History |
| 2024-09-30 09:31 am Purchase |
2024-09-24 | 13G | Rezolve AI Limited Ordinary Shares RZLV |
Apeiron Investment Group Ltd. | 18,281,638 10.400% |
18,281,638 (New Position) |
Filing History |
| 2024-02-13 4:29 pm Purchase |
2023-12-31 | 13G | Atai Life Sciences N.V. ATAI |
Apeiron Investment Group Ltd. | 33,885,999 20.100% |
1,214,297 (+3.72%) |
Filing History |
| 2023-06-02 5:00 pm Sale |
2023-06-01 | 13D | Sensei Biotherapeutics, Inc. SNSE |
Apeiron Investment Group Ltd. | 0 0.000% |
-3,441,661 (Position Closed) |
Filing History |
| 2023-05-23 4:50 pm Unchanged |
2023-05-23 | 13D | Sensei Biotherapeutics, Inc. SNSE |
Apeiron Investment Group Ltd. | 3,441,661 11.100% |
0 (Unchanged) |
Filing History |
| 2023-03-09 5:15 pm Purchase |
2023-03-09 | 13D | Sensei Biotherapeutics, Inc. SNSE |
Apeiron Investment Group Ltd. | 3,441,661 11.200% |
2,200 (+0.06%) |
Filing History |
| 2023-02-10 08:39 am Purchase |
2022-12-31 | 13G | Atai Life Sciences N.V. ATAI |
Apeiron Investment Group Ltd. | 32,671,702 19.400% |
612,198 (+1.91%) |
Filing History |
| 2022-11-21 06:15 am Unchanged |
2022-11-21 | 13D | Sensei Biotherapeutics, Inc. SNSE |
Apeiron Investment Group Ltd. | 3,439,461 11.200% |
0 (Unchanged) |
Filing History |
| 2022-11-02 11:58 am Unchanged |
2022-11-02 | 13D | Sensei Biotherapeutics, Inc. SNSE |
Apeiron Investment Group Ltd. | 3,439,461 11.200% |
0 (Unchanged) |
Filing History |
| 2022-07-19 5:30 pm Purchase |
2022-07-14 | 13D | Sensei Biotherapeutics, Inc. SNSE |
Apeiron Investment Group Ltd. | 3,439,461 11.200% |
210,000 (+6.50%) |
Filing History |
| 2022-02-10 5:15 pm Purchase |
2021-12-31 | 13G | Sensei Biotherapeutics, Inc. SNSE |
Apeiron Investment Group Ltd. | 3,229,461 10.600% |
577,618 (+21.78%) |
Filing History |
| 2022-02-10 5:01 pm Purchase |
2021-12-31 | 13G | Atai Life Sciences N.V. ATAI |
Apeiron Investment Group Ltd. | 32,059,504 19.700% |
32,059,504 (New Position) |
Filing History |
| 2021-12-30 4:31 pm Purchase |
2021-12-20 | 13D | Neuphoria Therapeutics Inc. NEUP |
Apeiron Investment Group Ltd. | 33,545,866 27.700% |
33,545,866 (New Position) |
Filing History |
| 2021-02-18 4:15 pm Purchase |
2021-02-08 | 13G | Sensei Biotherapeutics, Inc. SNSE |
Apeiron Investment Group Ltd. | 2,651,843 8.700% |
2,651,843 (New Position) |
Filing History |